欢迎来到实博

学术动态

您当前位置: 首页 > 学术蚌医 > 学术动态 > 正文

【实博】 我校最新SCI论文收录•2024-07期

发布者: 浏览量: 发布时间:2024-08-27

为了方便我校师生了解最新被Web of Science收录的我校作者发文情况,图书馆学科服务部定期收集最近数据库中最新收录的论文(包括在线发表)并以成果简报形式发布。

本期公布信息索引日期(即新输入到产品数据库中的数据)为2024.07.01---2024.07.31,检索默认来源为Web of Science核心合集,本期SCI-E数据库共收录我校师生论文92篇,包含ARTICLE 80篇、Review 5篇,其中第一作者或通讯作者论文58篇。影响因子5分以上论文概况如下:

1

篇名

In situ digestion-assisted multi-template imprinted nanoparticles for efficient analysis of protein phosphorylation

发表时间

2023

来源期刊

MICROCHIMICA ACTA

影响因子

5.3

本文作者

Wang, Jie; Zhao, Xiuling; Zhang, Hui; Chen, Yang; Bie, Zijun

第一作者

Wang, Jie(实博)

通讯作者

Bie, Zijun(实博)

关键词

PHOSPHOPEPTIDE ENRICHMENT; TYROSINE PHOSPHORYLATION; SELECTIVE ENRICHMENT; POLYMERS; TAU; PHOSPHOPROTEOMICS; GLYCOPROTEINS; RECOGNITION; MEMBRANE; RECEPTOR

DOI

10.1007/s00604-023-06081-7

2

篇名

Delivery of miR-15b-5p via magnetic nanoparticle-enhanced bone marrow mesenchymal stem cell-derived extracellular vesicles mitigates diabetic osteoporosis by targeting GFAP

发表时间

2024

来源期刊

CELL BIOLOGY AND TOXICOLOGY

影响因子

5.3

本文作者

Xu, Chen; Wang, Zhaodong; Liu, Yajun; Duan, Keyou; Guan, Jianzhong

第一作者

Xu, Chen(实博)

通讯作者

Guan, Jianzhong(实博)

关键词

EXOSOMES

DOI

10.1007/s10565-024-09877-2

3、

篇名

Evaluation of the Ocular Safety of Hollow Mesoporous Organosilica Nanoparticles with Different Tetrasulfur Bond Content

发表时间

2024

来源期刊

INTERNATIONAL JOURNAL OF NANOMEDICINE

影响因子

6.6

本文作者

Li, Juan; Gao, Ziqing; Li, Ning; Yao, Ling; Liu, Chao; Xu, Che; Ren, Xiaohui; Wang, Aiqin; Gao, Siqi; Wang, Miao; Gao, Xiang; Li, Kun; Wang, Jianfeng

第一作者

Li, Juan(实博)

通讯作者

Wang, Jianfeng(实博);Li, Kun(安徽科技学院)

关键词

SILICA NANOPARTICLES; HYDROGEN-SULFIDE; DELIVERY-SYSTEMS; DRUG; RELEASE; NANOCAPSULES; NANOCERIA; PLATFORM

DOI

10.2147/IJN.S464524


4

篇名

A Fe 2 O 3 /CNx cascade nanoreactor with dual-enzyme-mimetic activities for cancer hypoxia relief to amplify chemo/photodynamic therapy

发表时间

2024

来源期刊

COLLOIDS AND SURFACES B-BIOINTERFACES

影响因子

5.4

本文作者

Gan, Lu; Xia, Yongzhi; Lv, Jie; Xie, Jun; Yan, Yu; Chen, Yan

第一作者

Gan, Lu(实博)

通讯作者

Yan, Yu(实博); Chen, Yan(实博)

关键词

/

DOI

10.1016/j.colsurfb.2024.114070

5

篇名

Agricultural light-converting anti-icing superhydrophobic coating for plant growth promotion

发表时间

2024

来源期刊

CHEMICAL ENGINEERING JOURNAL

影响因子

13.3

本文作者

Xu, Xiaoyu; Shi, Shaoze; Sun, Baohong; Di, Shuying; Zhang, Juyang; Xie, Yuxin; Zhou, Ninglin

第一作者

Xu, Xiaoyu(南京师范大学)

通讯作者

Shi, Shaoze(南京师范大学);Zhou, Ninglin(南京师范大学)

关键词

UP-CONVERSION; QUANTUM DOTS; FILMS

DOI

10.1016/j.cej.2024.153286

6

篇名

Ultrastable fluorinated copolypeptide nanodroplets of loaded mixed liquids with low vaporization threshold

发表时间

2024

来源期刊

CHEMICAL ENGINEERING JOURNAL

影响因子

13.3

本文作者

Ye, Xianjun; Shao, Bing; Jiang, Xianxian; Li, Juan; Liu, Xiao; Chen, Xia; Cui, Yayun; Zhang, Chaoxue; Cen, Jie; He, Nianan

第一作者

Ye, Xianjun(中国科学技术大学)

通讯作者

He, Nianan(中国科学技术大学);Cen, Jie(中国科学技术大学);Zhang, Chaoxue(安徽医科大学)

关键词

ULTRASOUND CONTRAST AGENTS; BOILING-POINT; MICROBUBBLES; NANOPARTICLES

DOI

10.1016/j.cej.2024.153966

7

篇名

Recent research progress on tumour-specific responsive hydrogels

发表时间

2024

来源期刊

JOURNAL OF MATERIALS CHEMISTRY B

影响因子

6.1

本文作者

Zhou, Xuan-Yi; Wang, Chen-Kai; Shen, Ze-Fan; Wang, Yi-Fan; Li, Yu-Hang; Hu, Yu-Ning; Zhang, Pu; Zhang, Qi

第一作者

Zhou, Xuan-Yi(杭州师范大学、浙江省人民医院)

通讯作者

Zhang, Qi(杭州师范大学、浙江省人民医院、杭州医学院)

关键词

CELL ADHESION MOLECULE; PH; NANOPARTICLES; CHITOSAN; CANCER; NANOCARRIERS; THERAPY

DOI

10.1039/d4tb00656a

8

篇名

LILRB4 on multiple myeloma cells promotes bone lesion by p-SHP2/NF-κB/RELT signal pathway

发表时间

2024

来源期刊

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

影响因子

11.4

本文作者

Wang, Hongying; Wang, Lei; Luan, Huiwen; Xiao, Jing; Zhao, Zhiling; Yu, Pengfei; Deng, Mi; Liu, Yifan; Ji, Shuhao; Ma, Junjie; Zhou, Yan; Zhang, Jiashen; Meng, Xianhui; Zhang, Juan; Zhao, Xinyu; Li, Chunling; Li, Fangmin; Wang, Dapeng; Wei, Shujuan; Hui, Lijun; Nie, Siman; Jin, Changzhu; An, Zhiqiang; Zhang, Ningyan; Wang, Yaopeng; Zhang, Cheng Cheng; Li, Zunling

第一作者

Wang, Hongying(滨州医学院)

通讯作者

Li, Zunling(滨州医学院);Zhang, Cheng Cheng(德克萨斯大学西南医学中心);Wang, Yaopeng(康复大学)

关键词

INHIBITORY RECEPTOR ILT3; TUMOR-NECROSIS-FACTOR; IMMUNE CHECKPOINT; PLASMA-CELLS; EXPRESSION; DENOSUMAB; DEXAMETHASONE; SUPERFAMILY; SUPPRESSOR; BORTEZOMIB

DOI

10.1186/s13046-024-03110-y

9

篇名

SALIRI-based (raltitrexed plus irinotecan) therapy as a second-line treatment for patients with metastatic colorectal cancer (SALLY): A prospective, multicenter, non-interventional, registry study

发表时间

2024

来源期刊

CANCER COMMUNICATIONS

影响因子

20.1

本文作者

Qin, Shuqui; Li, Jin; Zhou, Aiping; Zhang, Yanqiao; Yuan, Xianglin; Zhu, Liangjun; Qin, Baoli; Zeng, Shan; Shen, Lin; Yuan, Ying; Wang, Weibo; Liang, Jun; Zhang, Xianwen; Ye, Feng; Chen, Ping; Wang, Huaizhang; Yu, Zhenyan; Yue, Lu; Fang, Yong; Xiong, Jianping; Yang, Jianwei; Wan, Yiye; Yin, Xianli; Wang, Wenling; Xu, Nong; Wang, Xiaohong; Xiao, Zemin; Su, Huafang; Wang, Ying; Gu, Kangsheng; Tu, Shuiping; Wang, Zishu; Liu, Bo; Hu, Xiaohua; Liu, Weixian; Li, Xiaofeng

第一作者

Qin, Shuqui(南京市江宁医院)

通讯作者

Li, Jin(上海市东方医院)

关键词

/

DOI

10.1002/cac2.12586

10

篇名

A multicentre randomized double-blind placebo-controlled phase III study of the efficacy and safety of xeligekimab (GR1501) in patients with moderate-to-severe plaque psoriasis

发表时间

2024

来源期刊

BRITISH JOURNAL OF DERMATOLOGY

影响因子

11

本文作者

Cai, Lin; Jiang, Congjun; Zhang, Guoqiang; Fang, Hong; Wang, Jinyan; Li, Yumei; Xu, Hui; Xiao, Rong; Ding, Yangfeng; Huang, Kun; Zhang, Chunlei; Zhang, Litao; Chen, Bin; Duan, Xinsuo; Pan, Weili; Han, Guangming; Chen, Rongyi; Liu, Lunfei; Zhang, Shoumin; Tao, Juan; Pang, Xiaowen; Yu, Jianbin; Wang, Huiping; Zhao, Yi; Li, Chengxin; Kang, Xiaojing; Qin, Lanying; Zhu, Xiaofang; Su, Juan; Li, Shanshan; Yang, Chunjun; Feng, Wenli; Lei, Tiechi; Jiang, Shan; Fang, Ruihua; Lin, Mao; Lu, Qianjin; Xu, Chunxing; Wang, Wei; Zhang, Jianzhong

第一作者

Cai, Lin(北京大学人民医院)

通讯作者

Zhang, Jianzhong(北京大学人民医院)

关键词

METABOLIC SYNDROME; JAPANESE PATIENTS; CHINESE PATIENTS; SECUKINUMAB; SUBANALYSIS; PREVALENCE; IXEKIZUMAB; ERASURE

DOI

10.1093/bjd/ljae062

11

篇名

Finotonlimab with chemotherapy in recurrent or metastatic head and neck cancer: a randomized phase 3 trial

发表时间

2024

来源期刊

NATURE MEDICINE

影响因子

58.7

本文作者

Shi, Yuankai; Guo, Wei; Wang, Wei; Wu, Yunteng; Fang, Meiyu; Huang, Xiaoming; Han, Ping; Zhang, Qingyuan; Dong, Pin; Zhou, Xiaohong; Peng, Hanwei; Hu, Chunhong; Chen, Xiaopin; Zhang, Shurong; Chang, Zhiwei; Li, Xiaojiang; Ding, Yuhai; Qu, Song; Jing, Shanghua; Zhang, Songnan; Gui, Lin; Sun, Yan; Wang, Lin; Liu, Yanyan; Wu, Hui; Li, Guoqing; Fu, Zhichao; Shi, Jianhua; Jiang, Hao; Bai, Yuansong; Cui, Jiuwei; Zheng, Yulong; Cui, Wei; Jia, Xiaojing; Zhai, Limin; Cai, Qingqing; Xiong, Deming; Wu, Yunong; Cao, Junning; Wu, Rong; Hu, Guangyuan; Peng, Liang; Xie, Liangzhi; Gai, Wenlin; Wang, Yan; Su, Yuehua

第一作者

Shi, Yuankai(中国医学科学院 北京协和医学院)

通讯作者

Shi, Yuankai(中国医学科学院 北京协和医学院)

关键词

SQUAMOUS-CELL CARCINOMA; 1ST-LINE TREATMENT; PLUS CETUXIMAB; PEMBROLIZUMAB; TRENDS

DOI

10.1038/s41591-024-03110-7